Rock Point Advisors, LLC Bristol Myers Squibb CO Transaction History

Rock Point Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $3 - $1,921	-25 Reduced 0.76%	3,285 $234,000
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $42,918 - $47,268	-591 Reduced 15.15%	3,310 $255,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $12,296 - $14,744	-200 Reduced 4.88%	3,901 $285,000
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $17,802 - $20,022	-300 Reduced 6.82%	4,101 $259,000
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $2,887 - $3,271	-50 Reduced 1.12%	4,401 $273,000
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $17,229 - $19,092	300 Added 7.23%	4,451 $268,000
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $11,832 - $17,194	-255 Reduced 5.79%	4,151 $231,000
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $216,819 - $282,821	4,406 New	4,406 $283,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Rock Point Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Rock Point Advisors, LLC with notifications on news.